Boaz Weinstein’s VSEE HEALTH INC WTS 29 VSEEW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.37K Hold
243,249
﹤0.01% 376
2026
Q1
$10.3K Hold
243,249
﹤0.01% 355
2025
Q4
$21.6K Hold
243,249
﹤0.01% 294
2025
Q3
$4.94K Hold
243,249
﹤0.01% 304
2025
Q2
$11.4K Hold
243,249
﹤0.01% 283
2025
Q1
$11.1K Hold
243,249
﹤0.01% 224
2024
Q4
$12.1K Hold
243,249
﹤0.01% 243
2024
Q3
$14.4K Hold
243,249
﹤0.01% 273
2024
Q2
$52.6K Sell
243,249
-7,600
-3% -$1.15K ﹤0.01% 237
2024
Q1
$37.4K Hold
250,849
﹤0.01% 267
2023
Q4
$6.54K Hold
250,849
﹤0.01% 426
2023
Q3
$5.54K Hold
250,849
﹤0.01% 524
2023
Q2
$16.7K Hold
250,849
﹤0.01% 507
2023
Q1
$21.3K Hold
250,849
﹤0.01% 625
2022
Q4
$24.8K Hold
250,849
﹤0.01% 717
2022
Q3
$32K Hold
250,849
﹤0.01% 900
2022
Q2
$26K Hold
250,849
﹤0.01% 970
2022
Q1
$37K Sell
250,849
-120,160
-32% -$28.1K ﹤0.01% 895
2021
Q4
$145K Buy
+371,009
New +$145K ﹤0.01% 685

Other funds holding VSEEW

Boaz Weinstein's VSEEW Position: Q2 2026 in Review

Boaz Weinstein held its VSEE HEALTH INC WTS 29 (VSEEW) position steady in Q2 2026 at 243,249 shares worth $7.37K. The position accounts for ﹤0.01% of the portfolio, ranked #376.

Boaz Weinstein first reported a position in VSEEW in Q4 2021 and has held it in 19 quarters since. The position peaked at $145K in Q4 2021. 19 funds tracked by Wall St. Rank hold VSEEW as of Q2 2026.

  • Boaz Weinstein held 243,249 shares of VSEE HEALTH INC WTS 29 worth $7.37K as of Q2 2026.
  • Boaz Weinstein left its VSEE HEALTH INC WTS 29 share count unchanged in Q2 2026.
  • VSEE HEALTH INC WTS 29 made up ﹤0.01% of Boaz Weinstein's portfolio in Q2 2026, its #376 holding.
  • Boaz Weinstein first reported a position in VSEE HEALTH INC WTS 29 in Q4 2021 and has held it in 19 quarters since.
  • Boaz Weinstein's VSEE HEALTH INC WTS 29 position peaked at $145K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held VSEE HEALTH INC WTS 29 as of Q2 2026.

Based on Saba Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.